维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="Raygada"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Glucagon - like peptide - 1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system jn RIN 1046 - 38 cells 显示文摘	Wang Y Egan JM Raygada M	1995	Endocrinology1995，136，：	1
	2	Managing CA-MRSA Infections: Cur- rent and Emerging options显示文摘	Raygada JL Levine DP	2009	Infections in Medicine2009，26，2：	1
	3	Prepubertal exposure to zearalenone or genistein reduces mammary tu-morigenesis 显示文摘	Hilakivi-Clarke L Onojafe I Raygada M	1999	British Journal of Cancer1999，80，11：	1
	4	Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells显示文摘	Wang Y Egan JM Raygada M	1995	Endocrinology1995，136，11：	1
	5	Juvenile xanthogranuloma in a child with previously unsuspeeted neurofibromatosis type 1 and juvenile myelomonoeytie leukemia显示文摘	Raygada M Arthur DC Wayne AS	2010	Pediatr Blood Cancer2010，54，1：	1
	6	Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046 - 38 cells 显示文摘	Wang Y EganJ M Raygada M	1995	Endocrinology1995，136，11：	1
	7	Multidrug efflux pump over expression in Staphylococcus aureus after single and multiple in vitro exposures to bio- cides and dyes显示文摘	HUETA A RAYGADA J L MENDIRATFA K	2008	Microbiol2008，154，10：	1
	8	Muhidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes 显示文摘	Huet AA Raygada JL Mendiratta K	2008	Microbiol2008，154，10：	1
	9	Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis显示文摘	Hilakivi Clarke L Onojafe I Raygada M	1999	Br J Cancer1999，80，11：	1
	10	Integrative gene network analysis provides novel regulatory relationships, genetic con- tributions and susceptible targets in autism spectrum disor ders显示文摘	Lee TL Raygada MJ Rennert OM	2012	Gene2012，496，2：	1
	11	Hereditary paragangliomas显示文摘	Raygada M Pasini B Stratakis CA		0，，：	1
	12	Glucagon-like peptide-1 af- fects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cell 显示文摘	Wang Y Egan J M Raygada M et a l	1995	Endocrinology1995，136，：	1
	13	Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis显示文摘	Hilakivi C L Onojafe I Raygada M	1999	Br J Cancer1999，80，：	1
	14	Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes显示文摘	Huet AA Raygada JL Mendiratta K	2008	Microbiology2008，154，10：	1
	15	Managing CA-MRSA infections: current and emerging options显示文摘	Raygada J L Levine D P	2009	Infect Med2009，26，2：	1
	16	自发性卵巢早衰女性生育脆性X染色体综合征儿显示文摘Objective: To inform clinicians about a reproductive risk associated with spontaneous premature ovarian failure and the fragile X mental retardation 1 gene (FMR1). Design: Case report. Setting: National Institutes of Health Clinical Center. Patient(s): A 35-year-old woman with confirmed spontaneous premature ovarian failure. Intervention(s): FMR1 genetic testing. Main Outcome Measure(s): Number of CGG trinucleotide repeats in the 5′untranslated region of FMR1. Result(s): Despite having ovarian failure the woman subsequently conceived and delivered a son with fragile X syndrome (>200 CGG repeats). She was then found to carry an FMR1 premutation (85 CGG repeats). Conclusion(s): This is a real-life manifestation of a theoretical risk; a woman conceived subsequent to the diagnosis of spontaneous premature ovarian failure and has a child who manifests mental retardation due to fragile X syndrome. Women with spontaneous premature ovarian failure are at increased risk of having an FMR1 premutation and should be informed of the availability of fragile X testing. Should an FMR1 premutation be uncovered, this will allow patients to make informed reproductive decisions and help clinicians to properly diagnose family members who may have menstrual irregularity, developmental delay, or neurologic symptoms.	Corrigan E.C. Raygada M.J. Vanderhoof V.H. Nelson L.M. 李跃萍	2006	世界核心医学期刊文摘(妇产科学分册)2006，0，3：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费